Igenomix Overview
- Year Founded
-
2011

- Status
-
Acquired/Merged
- Employees
-
560

- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
2
Igenomix General Information
Description
Provider of genetic testing services intended for reproductive health clinics. The company specializes in offering a range of services in reproductive genetics and specializes including NACE (non-invasive prenatal test), CGT (carrier genetic test), PGD (preimplantation genetic diagnosis), ERA (endometrial receptivity array) and creates and develops tools for the reproductive medicine field, thereby helping the clients couples who are trying to conceive.
Contact Information
Website
www.igenomix.com(Operating Subsidiary)
Corporate Office
- 7955 Northwest 12th Street
- Suite 415
- Miami, FL 33126
- United States
Corporate Office
- 7955 Northwest 12th Street
- Suite 415
- Miami, FL 33126
- United States
Igenomix Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Igenomix Comparisons
Industry
Financing
Details
Igenomix Competitors (37)
One of Igenomix’s 37 competitors is Ambry Genetics, a Formerly PE-Backed company based in Aliso Viejo, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
Admera Health | Venture Capital-Backed | South Plainfield, NJ | ||||
Exagen | Formerly VC-backed | Vista, CA | ||||
BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
MedGenome | Venture Capital-Backed | Wilmington, DE |
Igenomix Patents
Igenomix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4416305-A2 | Methods and reagents for the differential diagnosis of uterine tumors | Pending | 11-Oct-2021 | ||
US-20220220564-A1 | Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas | Pending | 17-Apr-2019 | ||
EP-3956476-A1 | Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas | Inactive | 17-Apr-2019 | ||
JP-2022529294-A | Improved methods for early diagnosis of uterine leiomyoma and leiomyoma | Pending | 17-Apr-2019 | ||
US-20210269862-A1 | Methods for assessing endometrial transformation | Inactive | 18-Jun-2018 | C12Q1/6816 |
Igenomix Signals
Igenomix Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Igenomix Investments (2)
Igenomix’s most recent deal was a Joint Venture with Novalbufera Business. The deal was made on 04-Jun-2021.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Novalbufera Business | 04-Jun-2021 | Joint Venture | Other Commercial Products | ||
Access Genomics | 14-Dec-2020 | Buyout/LBO | Laboratory Services (Healthcare) |
Igenomix Exits (1)
Igenomix’s most recent exit was on 14-Dec-2020 from Access Genomics. The exit was categorized as with 4 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Access Genomics | 14-Dec-2020 | Completed |
|
Igenomix FAQs
-
When was Igenomix founded?
Igenomix was founded in 2011.
-
Where is Igenomix headquartered?
Igenomix is headquartered in Miami, FL.
-
What is the size of Igenomix?
Igenomix has 560 total employees.
-
What industry is Igenomix in?
Igenomix’s primary industry is Laboratory Services (Healthcare).
-
Is Igenomix a private or public company?
Igenomix is a Private company.
-
What is the current valuation of Igenomix?
The current valuation of Igenomix is
. -
What is Igenomix’s current revenue?
The current revenue for Igenomix is
. -
Who are Igenomix’s investors?
Aleph Capital Partners, Amadeus Capital Partners, Charme Capital Partners, EQT, and are 5 of 7 investors who have invested in Igenomix.
-
Who are Igenomix’s competitors?
Ambry Genetics, Admera Health, Exagen, BGI Genomics, and MedGenome are some of the 37 competitors of Igenomix.
-
When was Igenomix acquired?
Igenomix was acquired on 30-Nov-2021.
-
Who acquired Igenomix?
Igenomix was acquired by Vitrolife.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »